InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: scottsmith post# 226037

Wednesday, 04/25/2018 1:10:27 PM

Wednesday, April 25, 2018 1:10:27 PM

Post# of 403074
If the 'interim' analysis was in the trial protocol submitted to FDA then it means it got FDA's sign-off. I can't stop wondering why FDA would do that, just for fun or to see if the IPIX bunch is really stupid enough to follow thru? Snapshot in mid-treatment and 10 weeks before the trial is guaranteed to be completed is, as far as I can tell, a sizeable waste of money plus, also, a very unusual interim analysis design in a time limited, blinded, interventional psoriasis trial. It does not have any cost savings or patient benefit value as futility stop measure and a limited value as a predictor for the significance of the final outcome.

Yes, IPIX may have run the analysis anyway. I doubt if seeing the results told them a thing beyond prurisol not being in the class of biologics and that fact was known already. Still, it may have been enough to silence Leo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News